United Therapeutics Corp (FRA:UTH)
€ 245.3 4.6 (1.91%) Market Cap: 10.88 Bil Enterprise Value: 8.92 Bil PE Ratio: 12.50 PB Ratio: 2.19 GF Score: 89/100

United Therapeutics Corp at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 05:30PM GMT
Release Date Price: €74.02 (-0.31%)
Eun Kyung Yang
Jefferies LLC, Research Division - MD & Senior Equity Research Analyst

Good afternoon. This is Eun Yang, a biotech analyst with Jefferies. Our next presenting company is United Therapeutics. And presenting from UTHR is James Edgemond, CFO of the company. James?

James C. Edgemond
United Therapeutics Corporation - CFO & Treasurer

Yes. Eun, thank you very much for the introduction, and thank you for the opportunity to present United Therapeutics at your 2019 Healthcare Conference this afternoon.

In addition, thank you for inviting us to the conference. We've had some great conversations this morning, and I'm looking forward to sharing more of those conversations with this audience as well as those on the webcast. I am joined today by Michael Benkowitz, who is United Therapeutics' President and Chief Operating Officer.

Good afternoon to everyone here in the room and also those joining on the webcast for attending our presentation this afternoon.

I want to start the presentation by reviewing our safe harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot